Global Antifungal infection Therapeutics Market Analysis & Trends - Drug Type (Allylamines, Polyenes, Echinocandins and Azoles) - Forecast to 2025

  • ID: 3971830
  • Report
  • Region: Global
  • 140 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Asperqillus
  • Bayer Healthcare
  • Gilead
  • Kramer Laboratories
  • Novartis
  • MORE
The Global Antifungal infection Therapeutics Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market is witnessing include huge number of infections are caused by aspergillus and candida fungus, introduction of new drugs, recent technological developments of Antifungal infection Therapeutics and growth opportunities/investment opportunities.

Based on drug type the market is categorized into allylamines, polyenes, echinocandins and azoles.

This industry report analyzes the global markets for Antifungal infection Therapeutics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Antifungal infection Therapeutics Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Asperqillus
  • Bayer Healthcare
  • Gilead
  • Kramer Laboratories
  • Novartis
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Strategic Benchmarking
1.5 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Huge Number of Infections are Caused by Aspergillus and Candida Fungus
3.1.2 Introduction of New Drugs
3.1.3 Recent Technological Developments of Antifungal infection Therapeutics
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Antifungal infection Therapeutics Market, By Drug Type
4.1 Allylamines
4.1.1 Allylamines Market Forecast to 2025 (US$ MN)
4.2 Polyenes
4.2.1 Polyenes Market Forecast to 2025 (US$ MN)
4.3 Echinocandins
4.3.1 Echinocandins Market Forecast to 2025 (US$ MN)
4..4 Azoles
4.4.1 Azoles Market Forecast to 2025 (US$ MN)

5 Antifungal infection Therapeutics Market, By Geography
5.1 North America
5.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
5.1.1.1 US
5.1.1.2 Canada
5.1.1.3 Mexico

5.2 Europe
5.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
5.2.1.1 France
5.2.1.2 Germany
5.2.1.3 Italy
5.2.1.4 Spain
5.2.1.5 U.K.
5.2.1.6 Rest of Europe

5.3 Asia Pacific
5.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
5.3.1.1 Japan
5.3.1.2 China
5.3.1.3 India
5.3.1.4 Australia
5.3.1.5 New Zealand
5.3.1.6 Rest of APAC

5.4 Middle East
5.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
5.4.1.1 Saudi Arabia
5.4.1.2 UAE
5.4.1.3 Rest of Middle East

5.5 Latin America
5.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
5.5.1.1 Argentina
5.5.1.2 Brazil
5.5.1.3 Rest of Latin America

5.5 Rest of the World (RoW)
5.5.1 RoW Market Forecast by Countries to 2025 (US$ MN)
5.5.1.1 Africa
5.5.1.2 Caribbean

6 Key Player Activities
6.1 Mergers & Acquisitions
6.2 Partnerships, Joint Venture’s, Collaborations and Agreements
6.3 Product Launch & Expansions
6.4 Other Activities

7 Leading Companies
7.1 Novartis
7.2 Gilead
7.3 Asperqillus
7.4 Glaxosmithkline
7.5 Kramer Laboratories
7.6 Alternaria
7.7 Sanofi-Aventis
7.8 Pfizer
7.9 Enzon Pharmaceuticals
7.10 Abbott Laboratories
7.11 SCYNEXIS Inc.
7.12 Bayer Healthcare
7.13 Merck & Co.
7.14 Astellas Pharma Inc.

List of Tables

Table 1 Global Antifungal infection Therapeutics Market By Region, Market Forecast (2013-2025) (US$ MN)
Table 2 Global Antifungal infection Therapeutics Market By Drug Type, Market Forecast (2013-2025) (US$ MN)
Table 3 Global Antifungal infection Therapeutics Market By Allylamines, Market Forecast (2013-2025) (US$ MN)
Table 4 Global Antifungal infection Therapeutics Market By Polyenes, Market Forecast (2013-2025) (US$ MN)
Table 5 Global Antifungal infection Therapeutics Market By Echinocandins, Market Forecast (2013-2025) (US$ MN)
Table 6 Global Antifungal infection Therapeutics Market By Azoles, Market Forecast (2013-2025) (US$ MN)
Table 7 North America Antifungal infection Therapeutics Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 8 North America Antifungal infection Therapeutics Market By Drug Type, Market Forecast (2013-2025) (US$ MN)
Table 9 North America Antifungal infection Therapeutics Market By Allylamines, Market Forecast (2013-2025) (US$ MN)
Table 10 North America Antifungal infection Therapeutics Market By Polyenes, Market Forecast (2013-2025) (US$ MN)
Table 11 North America Antifungal infection Therapeutics Market By Echinocandins, Market Forecast (2013-2025) (US$ MN)
Table 12 North America Antifungal infection Therapeutics Market By Azoles, Market Forecast (2013-2025) (US$ MN)
Table 13 Europe Antifungal infection Therapeutics Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 14 Europe Antifungal infection Therapeutics Market By Drug Type, Market Forecast (2013-2025) (US$ MN)
Table 15 Europe Antifungal infection Therapeutics Market By Allylamines, Market Forecast (2013-2025) (US$ MN)
Table 16 Europe Antifungal infection Therapeutics Market By Polyenes, Market Forecast (2013-2025) (US$ MN)
Table 17 Europe Antifungal infection Therapeutics Market By Echinocandins, Market Forecast (2013-2025) (US$ MN)
Table 18 Europe Antifungal infection Therapeutics Market By Azoles, Market Forecast (2013-2025) (US$ MN)
Table 19 Asia Pacific Antifungal infection Therapeutics Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 20 Asia Pacific Antifungal infection Therapeutics Market By Drug Type, Market Forecast (2013-2025) (US$ MN)
Table 21 Asia Pacific Antifungal infection Therapeutics Market By Allylamines, Market Forecast (2013-2025) (US$ MN)
Table 22 Asia Pacific Antifungal infection Therapeutics Market By Polyenes, Market Forecast (2013-2025) (US$ MN)
Table 23 Asia Pacific Antifungal infection Therapeutics Market By Echinocandins, Market Forecast (2013-2025) (US$ MN)
Table 24 Asia Pacific Antifungal infection Therapeutics Market By Azoles, Market Forecast (2013-2025) (US$ MN)
Table 25 Middle East Antifungal infection Therapeutics Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 26 Middle East Antifungal infection Therapeutics Market By Drug Type, Market Forecast (2013-2025) (US$ MN)
Table 27 Middle East Antifungal infection Therapeutics Market By Allylamines, Market Forecast (2013-2025) (US$ MN)
Table 28 Middle East Antifungal infection Therapeutics Market By Polyenes, Market Forecast (2013-2025) (US$ MN)
Table 29 Middle East Antifungal infection Therapeutics Market By Echinocandins, Market Forecast (2013-2025) (US$ MN)
Table 30 Middle East Antifungal infection Therapeutics Market By Azoles, Market Forecast (2013-2025) (US$ MN)
Table 31 Latin America Antifungal infection Therapeutics Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 32 Latin America Antifungal infection Therapeutics Market By Drug Type, Market Forecast (2013-2025) (US$ MN)
Table 33 Latin America Antifungal infection Therapeutics Market By Allylamines, Market Forecast (2013-2025) (US$ MN)
Table 34 Latin America Antifungal infection Therapeutics Market By Polyenes, Market Forecast (2013-2025) (US$ MN)
Table 35 Latin America Antifungal infection Therapeutics Market By Echinocandins, Market Forecast (2013-2025) (US$ MN)
Table 36 Latin America Antifungal infection Therapeutics Market By Azoles, Market Forecast (2013-2025) (US$ MN)
Table 37 RoW Antifungal infection Therapeutics Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 38 RoW Antifungal infection Therapeutics Market By Drug Type, Market Forecast (2013-2025) (US$ MN)
Table 39 RoW Antifungal infection Therapeutics Market By Allylamines, Market Forecast (2013-2025) (US$ MN)
Table 40 RoW Antifungal infection Therapeutics Market By Polyenes, Market Forecast (2013-2025) (US$ MN)
Table 41 RoW Antifungal infection Therapeutics Market By Echinocandins, Market Forecast (2013-2025) (US$ MN)
Table 42 RoW Antifungal infection Therapeutics Market By Azoles, Market Forecast (2013-2025) (US$ MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Alternaria
  • Asperqillus
  • Astellas Pharma Inc.
  • Bayer Healthcare
  • Enzon Pharmaceuticals
  • Gilead
  • Glaxosmithkline
  • Kramer Laboratories
  • Merck & Co.
  • Novartis
  • Pfizer
  • SCYNEXIS Inc.
  • Sanofi-Aventis
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll